While for some adults, attention-deficit/hyperactivity disorder (ADHD) is relatively mild and, with effective treatment, does not have a significant impact on overall functioning or quality of life. However, it is noteworthy that the majority of [...]
To address the growing demand for specialized knowledge in perinatal psychiatry, the Center for Women's Mental Health is pleased to announce its newest CME course offering: Perinatal Psychiatry: In Depth Modules for Enhanced Approaches. [...]
While many women experience physical symptoms prior to the onset of their period or premenstrual syndrome (PMS), a smaller subset of women suffer from Premenstrual Dysphoric Disorder (PMDD), a more severe form of premenstrual [...]
While many women experience physical symptoms prior to the onset of their period or premenstrual syndrome (PMS), a smaller subset of women suffer from Premenstrual Dysphoric Disorder (PMDD), a more severe form of premenstrual [...]
We completed our first MGH Women’s Mental Health online CME program in the Fall of 2019, and we are so excited to offer our next round of the course beginning in November 2020. Thank you [...]
Back by popular demand, the Center for Women's Mental Health is pleased to announce a second course offering of Psychiatric Disorders in Women: Diagnostic and Treatment Considerations Across the Female Lifespan with the MGH [...]
There is excellent data to support the use of selective serotonin and serotonin- norepinephrine reuptake inhibitors (SSRIs and SNRIs) for the treatment of premenstrual dysphoric disorder (PMDD); however, many women do not want to [...]
There is excellent data to support the use of selective serotonin and serotonin-norepinephrine reuptake inhibitors (SSRIs and SNRIs) for the treatment of premenstrual dysphoric disorder (PMDD); however, many women do not want to take [...]
Allopregnanolone is all over the place these days. We have seen several different allopregnanolone derivatives being used to treat postpartum depression (PPD). Last year, intravenous brexanolone (Zulresso) was approved by the FDA as the [...]
We completed our first MGH Women’s Mental Health online CME program in the Fall of 2019, and we are excited to offer the next round of the course in the series. Thank you for those [...]
